Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment With Aspirin After Preeclampsia: TAP Trial

NCT06281665 is registered in ClinicalTrials.gov with Malamo Countouris as lead sponsor.

NCT NCT06281665
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06281665 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment With Aspirin After Preeclampsia: TAP Trial
Lead sponsor
Malamo Countouris
Phase
Phase 4
Overall status
Recruiting
Start date
May 29, 2024
Completion date
October 1, 2027
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiovascular diseases, eclampsia, gestational hypertension, hypertension, hypertension, pregnancy induced, hypertension;pre-eclamptic, hypertensive disorder of pregnancy, pre-eclampsia, pregnancy complications, toxemia, vascular diseases